Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Lambertini

Showing results (191-200 of 375) with videos related to

Pageof 38
Sort By:
Oncology Research|July 26, 2024
Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature reviewAna S Cvetanovic, Matteo Lambertini, Kevin Punie, et al.
The Oncologist|June 22, 2023
Healthcare Professional Communication on Sexual Health: A Report from the Italian Working Group on Adolescents and Young Adults with CancerPaola Quarello, Angela Toss, Paola Berchialla, et al.
Journal of Geriatric Oncology|October 5, 2023
Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinomaAndrea Boutros, Elena Croce, Enrica Teresa Tanda, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialistsMarie-Madeleine Dolmans, Matteo Lambertini, Kirsten Tryde Macklon, et al.
JCO Oncology Practice|June 24, 2020
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research ActivitiesFrancesca Poggio, Marco Tagliamento, Massimo Di Maio, et al.
Breast (Edinburgh, Scotland)|January 18, 2025
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancerPaola Zagami, Angela Esposito, Beatrice Taurelli Salimbeni, et al.
NPJ Breast Cancer|August 16, 2018
Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutationsBastien Nguyen, David Venet, Hatem A Azim, et al.
Critical Reviews in Oncology/Hematology|May 25, 2025
The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspectsDemi Wekking, Carolina Alves Costa Silva, Roberto Viscò, et al.
Breast (Edinburgh, Scotland)|June 4, 2026
EBCC-15 manifesto: Removing age-related barriers to improve equity in breast cancer careFiorita Poulakaki, Etienne Brain, Icro Meattini, et al.
European Journal of Clinical Investigation|June 15, 2020
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreakMarco Tagliamento, Francesco Spagnolo, Francesca Poggio, et al.
Pageof 38

Showing results (191-200 of 375) with videos related to

Sort By:
Pageof 38
Oncology Research|July 26, 2024
Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature reviewAna S Cvetanovic, Matteo Lambertini, Kevin Punie, et al.
The Oncologist|June 22, 2023
Healthcare Professional Communication on Sexual Health: A Report from the Italian Working Group on Adolescents and Young Adults with CancerPaola Quarello, Angela Toss, Paola Berchialla, et al.
Journal of Geriatric Oncology|October 5, 2023
Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinomaAndrea Boutros, Elena Croce, Enrica Teresa Tanda, et al.
Critical Reviews in Oncology/Hematology|May 17, 2019
EUropean REcommendations for female FERtility preservation (EU-REFER): A joint collaboration between oncologists and fertility specialistsMarie-Madeleine Dolmans, Matteo Lambertini, Kirsten Tryde Macklon, et al.
JCO Oncology Practice|June 24, 2020
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research ActivitiesFrancesca Poggio, Marco Tagliamento, Massimo Di Maio, et al.
Breast (Edinburgh, Scotland)|January 18, 2025
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancerPaola Zagami, Angela Esposito, Beatrice Taurelli Salimbeni, et al.
NPJ Breast Cancer|August 16, 2018
Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutationsBastien Nguyen, David Venet, Hatem A Azim, et al.
Critical Reviews in Oncology/Hematology|May 25, 2025
The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspectsDemi Wekking, Carolina Alves Costa Silva, Roberto Viscò, et al.
Breast (Edinburgh, Scotland)|June 4, 2026
EBCC-15 manifesto: Removing age-related barriers to improve equity in breast cancer careFiorita Poulakaki, Etienne Brain, Icro Meattini, et al.
European Journal of Clinical Investigation|June 15, 2020
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreakMarco Tagliamento, Francesco Spagnolo, Francesca Poggio, et al.
Pageof 38